Affimed
AFMD
$5.31
Share price
-0.52%
Change (1 day)
496.87%
Change (1 year)
Categories
Market capitalization of Affimed (AFMD)
Market cap: $80.89 Million
As of May 2024 Affimed has a market cap of $80.89 Million. This makes Affimed the world's 7544th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Affimed from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $80.89 M | -13.34% |
| 2023 | $93.33 M | -49.6% |
| 2022 | $0.18 B | -72% |
| 2021 | $0.66 B | 15.8% |
| 2020 | $0.57 B | 173.33% |
| 2019 | $0.20 B | 7.61% |
| 2018 | $0.19 B | 234.34% |
| 2017 | $58.07 M | -3% |
| 2016 | $59.86 M | -74.72% |
| 2015 | $0.23 B | 59.25% |
| 2014 | $0.14 B |
End of Day market cap according to different sources
On May 15th, 2024 the market cap of Affimed was reported to be:
$81.62 Million
$81.62 Million
$81.31 Million
$80.17 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Repligen
RGEN | $9.65 B | 11,838.82% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.22 B | 171.99% | 🇺🇸 USA |
 Agenus
AGEN | $0.21 B | 170.51% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.82 M | -98.99% | 🇺🇸 USA |